Anand Rathi Recommends Buying Artemis Medicare Services, Sets Rs 390 Target

Anand Rathi described Artemis Medicare Services’ Q2FY27 performance as healthy and broadly in line with its estimates, with EBITDA up 8% year over year. It cited better inpatient volume, higher occupancy and improved ARPOB.